Results of an open-label study of high-dose liposomal amphotericin B (AmBisome) in the treatment of confirmed fungal infections in high-risk patients

被引：0
作者：
Kinsey, S
Jackson, G
Holyoake, T
McCann, S
Gibson, B
机构：
[1] St James Hosp, Dept Paediat Haematol, Leeds LS9 7TF, W Yorkshire, England
[2] Royal Victoria Infirm, Dept Haematol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[3] Glasgow Royal Infirm, Dept Haematol, Glasgow G4 0SF, Lanark, Scotland
[4] St James Hosp, Dept Haematol, Dublin 8, Ireland
[5] Royal Hosp Sick Children, Dept Haematol, Glasgow G3 8SJ, Lanark, Scotland
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2004年 / 125卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
202
引用
收藏
页码：62 / 63
页数：2
相关论文
共 50 条
[31]   A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study [J].
Thakur, CP .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 17 (01) :67-70
[32]   Amphotericin B lipid complex (ABLC) for fungal sepsis in high-risk immunocompromised patients [J].
Mehta, J ;
Powles, R ;
Singhal, S ;
Jameson, B ;
Treleaven, J .
EUROPEAN JOURNAL OF CANCER, 1995, 31A :1221-1221
[33]   Results of High-Dose Treosulfan-Containing Regimen in Patients With High-Risk Neuroblastoma [J].
Shamanskaya, T. ;
Kachanov, D. ;
Hachatryan, L. ;
Khismatullina, R. ;
Moiseenko, R. ;
Teleshova, M. ;
Skorobogatova, E. ;
Druy, A. ;
Zemcova, L. ;
Kurnikova, E. ;
Tereschenko, G. ;
Nechesnyuk, A. ;
Akhaladze, D. ;
Fomin, D. ;
Konovalov, D. ;
Grachev, N. ;
Likar, Y. ;
Maschan, M. ;
Varfolomeeva, S. ;
Novichkova, G. .
PEDIATRIC BLOOD & CANCER, 2020, 67 :S170-S170
[34]   LIPOSOMAL AMPHOTERICIN-B FOR THE TREATMENT OF SYSTEMIC FUNGAL-INFECTIONS IN PATIENTS WITH CANCER - A PRELIMINARY-STUDY [J].
LOPEZBERESTEIN, G ;
FAINSTEIN, V ;
HOPFER, R ;
MEHTA, K ;
SULLIVAN, MP ;
KEATING, M ;
ROSENBLUM, MG ;
MEHTA, R ;
LUNA, M ;
HERSH, EM ;
REUBEN, J ;
JULIANO, RL ;
BODEY, GP .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (04) :704-710
[35]   AMBIZYGO:: phase II study of high dose liposomal amphotericin B (AmBisome®) [10 mg/kg/j] efficacy against zygomycosis [J].
Lanternier, F. ;
Lortholary, O. .
MEDECINE ET MALADIES INFECTIEUSES, 2008, 38 :S90-S91
[36]   Liposomal amphotericin B standard dose in combination with caspofungin versus liposomal amphotericin B high dose regimen for the treatment of invasive aspergillosis in immunocompromised patients:: randomised pilot study (Combistrat Trial) [J].
Caillot, D. ;
Thiebaut, A. ;
Herbrecht, R. ;
Pigneux, A. ;
de Botton, S. ;
Attal, M. ;
Bernard, F. ;
Larche, J. ;
Alfandari, S. ;
Monchecourt, F. ;
Mahi, L. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 :S260-S260
[37]   High-dose chemotherapy as adjuvant treatment for high-risk primary breast cancer patients [J].
Bertuzzi, A ;
Gullo, G ;
Rimassa, L ;
Castagna, L ;
Santoro, A .
ANNALS OF ONCOLOGY, 2006, 17 (04) :719-720
[38]   The effectiveness of high-dose escitalopram in the treatment of patients suffering from schizophrenia with comorbid obsessive-compulsive disorder: an open-label study [J].
Rubin-Kahana, Dafna Sara ;
Shelef, Assaf ;
Weizman, Abraham ;
Gothelf, Doron ;
Timinski, Igor ;
Spivak, Baruch ;
Stryjer, Rafael .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019, 34 (04) :179-183
[39]   Alirocumab in high-risk patients: Observations from the open-label expanded use program [J].
Glueck, Charles J. ;
Brown, Alan ;
Goldberg, Anne C. ;
McKenney, James M. ;
Kantaros, Louis ;
Stewart, John ;
Elassal, Joseph ;
Koren, Andrew .
JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (03) :662-668
[40]   Treatment of confirmed and suspected invasive fungal infections with liposomal amphotericin B in patients with a hemtological malignancy in a tertiary care hospital in 1991-2000 [J].
Salonen, JH ;
Remes, K ;
Salmi, TT ;
Nikoskelainen, J .
BONE MARROW TRANSPLANTATION, 2002, 29 :S248-S248
12345